Switzer TV

 

Welcome back for another year of stock picks, top LICs and trading tips with Switzer Investing TV. Good to have you aboard.

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

In this first show of the year, Peter Switzer sits down with Adam Dawes from Shaw and Partners, Mike Gable from Fairmont Equities, and Paul Rickard from the Switzer Report to cut through the noise.

They run the ruler over some of the market’s most talked-about names, including CSL, NextDC, Xero, WiseTech, Pro Medicus, lithium plays, uranium stocks, and gold. Fundamentals meet charts, sentiment clashes with valuation, and the panel doesn’t always agree. You’ll hear why great businesses can fall a long way without anything being “wrong”, what the charts are really saying about beaten-up tech, why resources have momentum again, and whether gold is still a defensive play with upside in 2026.

Switzer Investing TV (19/12/25): Are these smashed stocks worth your time?

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

More videos

Mad about Money Live

Tune in to find out the latest money news and how it affects you!

Series:
Why Altium is up 34%? Experts like: IGO, TRO, XRO, TPG & turning a bad investment into a tax gain!

On this episode, Peter Switzer is joined by Julia Lee of Burman Invest, Adam Dawes from Shaw and Partners and Paul Rickard.

Series:
A new therapy for Pancreatic Cancer

Dr Ross Walker explains how pancreatic cancer works and how an Australian company is developing a new therapy to improve the survival rate of this cancer.

Series:
Are these ASX hot stocks a buy: AIS, ALC, MP1, AD8 + The CEO of Bendigo Bank, is this a buy too?

Medallion Financial Group's Michael Wayne, Bendigo and Adelaide Bank's Marnie Baker and Neuberger Berman's Vivek Bommi join Peter Switzer.

Series:
Mad about Money Live

Tune in to hear Peter Switzer and Paul Rickard discuss all the big money stories of the day!

Series:
ALU & APX really a buy? Should you buy Woolies ahead of the demerger with Dan Murphy's?

Burman Invest's Julia Lee, Fairmont Equities' Michael Gable and Switzer's Paul Rickard join the show.

Series:
A new treatment for tinnitus

Almost 20% of the population suffer from the annoying condition called Tinnitus, which presents as a ringing noise in the ear. Dr Ross Walker discusses the ‘poor man’s’ treatment and a new promising treatment for the condition.

Series:
Charlie Aitken names his best OS and OZ stocks: MSFT, MC, GOOGL, CSL & more

Aitken Investment Management's Charlie Aitken, nabtrade's Gemma Dale and Switzer's Paul Rickard join the show.

Series:
Mad about Money Live

Find out the latest money news and how it affects you with Peter Switzer and Paul Rickard.

Series:
ASX Stocks the experts like: Z1P, ALU, CSL, GNC & is EML a buy after the sell-off?

Burman Invest's Julia Lee, Shaw and Partners' Adam Dawes and Switzer's Paul Rickard join Peter Switzer on this week's show.

Series:
Coming soon: exciting new technology that could change medicine as we know it

Dr Ross Walker explains microneedle patch technology and how it will revolutionise treatments for diabetics, people with high cholesterol and anyone needing injections or vaccinations.

Series:
Are these ASX stocks a buy: NXL, AVH, TWE, MP1, ALL, XRO + how to borrow to buy stocks?

Michael Gable from Fairmont Equities, Paul Rickard from Switzer, Lily Elliott from Bendigo and Adelaide Bank, and Ying Yi Ann Cheng from Coolabah Capital join Peter Switzer.

Series:
1 30 31 32 33 34 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram